Crown's Skinpen Scores New Indications in the EU and UK

The new certification confirms SkinPen Precision as a treatment which can help to improve the appearance of surgical scars, stretch marks, and enlarged pores on all areas of the body.

Crown Aesthetics’ SkinPen Precision scored three new approved indications in the EU and UK. The new certification confirms SkinPen Precision as a treatment which can help to improve the appearance of surgical scars, stretch marks, and enlarged pores on all areas of the body.

The device is also approved to treat facial acne scars in adults aged 22 years or older and for aesthetic purposes to help improve the cosmetic appearance of fine lines, wrinkles, and pigmentation conditions.

"As a brand, we are continually raising the bar in the microneedling market," says Andy Moulton, Vice President, Sales, International for Crown Aesthetics, in a news release. "This new certification not only solidifies our status as the leading, most advanced skin remodeling treatment system, but it also enables us to further our global consumer reach. We are committed to supporting our customers' skin health journey by helping them visibly transform and improve the appearance of their skin without surgical intervention."